Tata Elxsi Q4 FY25: Revenue ₹908 Cr, PAT ₹172 Cr

What Tata Elxsi reported for Q4 FY25

Tata Elxsi announced its Q4 FY25 results for the quarter ended March 31, 2025, with consolidated revenue from operations at ₹908.3 crore. The figure was down 3.3% quarter-on-quarter from ₹939.2 crore in Q3 FY25. Year-on-year, revenue was largely flat, up 0.3% versus ₹905.9 crore in Q4 FY24. Profit after tax (PAT) came in at ₹172.4 crore, down 13.4% QoQ and 12.4% YoY. The company said the quarter was impacted by macroeconomic and geopolitical headwinds, particularly in transportation and media-related work.

Margins contracted as EBITDA declined sequentially

Operating profitability softened in Q4 FY25. EBITDA was ₹207.7 crore, down 15.8% QoQ from ₹246.6 crore in Q3 FY25 and down 20.5% YoY from ₹261.2 crore in Q4 FY24. The EBITDA margin fell to 22.9% in Q4 FY25 from 26.3% in Q3 FY25 (Q4 FY24: 28.8%). PAT margin also contracted to 18.1% from 20.3% in the previous quarter (Q4 FY24: 21.0%). The results indicate a weaker quarter on both revenue and profitability compared with the immediately preceding quarter.

Full-year FY25: revenue up, profit slightly lower

For FY25, Tata Elxsi reported revenue from operations of ₹3,729.0 crore, up 5.0% from ₹3,552.1 crore in FY24. Total income for the year stood at ₹3,908.4 crore, compared with ₹3,674.1 crore in FY24. PAT for FY25 was ₹784.9 crore, down 0.9% from ₹792.2 crore in FY24. EBITDA for FY25 was ₹972.9 crore, lower than ₹1,046.4 crore in FY24, and the EBITDA margin for the year was 26.1% versus 29.5% in FY24. The company also reported FY25 PBT of ₹1,028.4 crore versus ₹1,048.7 crore in FY24.

Segment trends: transportation and media weaker, healthcare better

Management commentary pointed to demand softness and delays in specific verticals during the quarter. In the transportation segment, revenue fell 9.7% QoQ in constant currency terms, linked to project pauses by clients. Media and communications revenue declined 6.3% QoQ, with the company citing cautious industry spending and customer-specific issues related to mergers and restructuring. In contrast, healthcare and life sciences grew 3.5% QoQ in constant currency terms, supported by Gen AI-powered offerings and new client wins. The segment split highlights that weakness was not broad-based, but concentrated in two large verticals.

Deal wins highlighted by the company

Despite the softer quarter, Tata Elxsi flagged large deal wins that it said support future revenue visibility. CEO and MD Manoj Raghavan highlighted a €50 million multi-year automotive SDV (software-defined vehicle) and software engineering deal with a European automotive leader. He also referred to a $100+ million multi-year media engineering engagement, described as a strategic product engineering consolidation deal and the company’s largest-ever single deal. In management’s commentary, the automotive business faced challenges as some OEMs and suppliers paused new program starts amid geopolitical, business, and market uncertainties. The company also said it saw delays in ramp-ups for deals won in earlier quarters, which it expects to resume starting Q1 FY26.

Dividend announcement for FY2024-25

Tata Elxsi’s board of directors recommended a final dividend of ₹75 per equity share (face value ₹10) for FY2024-25. The dividend is subject to shareholder approval at the upcoming Annual General Meeting. Dividend recommendations are typically tracked closely in IT services given their link to cash generation and capital allocation discipline. The announcement came alongside management’s focus on a strong balance sheet and operating cash flow, as referenced in the broader results coverage.

Key numbers at a glance (₹ in crore)

Market reaction and stock levels cited in reports

In the trading session referenced alongside the results, Tata Elxsi shares were reported to have closed 0.62% lower at ₹4,899.75 on the BSE. A separate market snapshot mentioned the stock closing at ₹4,755.15 on April 17, along with a market capitalisation of ₹29,620.40 crore and a P/E ratio of 36.59. These datapoints reflect the market’s focus on margin movement, vertical-specific softness, and the pace of deal ramp-ups.

Why the Q4 FY25 print matters

The Q4 FY25 outcome shows a clear pattern: revenue was nearly flat year-on-year, but profitability weakened versus both the previous quarter and the year-ago quarter. The EBITDA margin moved down to 22.9% from 26.3% in Q3 FY25, while PAT declined 13.4% sequentially. Management attributed part of the softness to pauses in new program starts in automotive and client caution in media and communications. At the same time, the company positioned large deal wins, including the €50 million SDV deal and the $100+ million media deal, as key anchors for the coming quarters.

What to track next

Investors will likely watch for execution on the announced large deal wins and whether ramp-ups resume as indicated from Q1 FY26. Segment momentum in healthcare and life sciences, which posted 3.5% QoQ constant currency growth, will also be a monitorable offset to weakness in transportation and media. The final dividend of ₹75 per share will be subject to shareholder approval at the AGM. The results and related figures were cited as being sourced from Tata Elxsi’s Q4 FY25 investor presentation and BSE filings, with the report updated on March 17, 2026.